Clinuvel Pharmaceuticals Limited announced that Non-Executive Director Sir Andrew Likierman, who has been a member of the Board of Directors
since April 2022, will resign from his position at the conclusion of the AGM to focus on his various academic and consultancy activities. Mr. Willem Blijdorp has announced he will step down as Chairperson of the Board of Directors
with effect from of 1 January 2024, pending his re-election as a Non-Executive Director at the
Company's AGM. The Board has commenced a review process, after which a new Chairperson
will be announced.